<DOC>
	<DOCNO>NCT01754844</DOCNO>
	<brief_summary>This First Human study ass safety tolerability AZD7624 , follow inhaled administration single ascend dos healthy male volunteer female volunteer non-child bearing potential . Pharmacokinetics ( body drug ) pharmacodynamic ( drug body ) parameter also assess secondary objective .</brief_summary>
	<brief_title>A First Time Man Study Asses Safety Tolerability AZD7624 Healthy Subjects</brief_title>
	<detailed_description>A Double-blind Placebo-controlled , Randomised , Single centre , First Time Man Study evaluate Safety , Tolerability , Pharmacokinetics Pharmacodynamics Single Ascending Inhaled Doses AZD7624 Healthy Subjects</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Healthy male and/or female subject age 18 55 year Able inhale SPIRA nebuliser accord provide instruction Females must negative pregnancy test screen admission ( Day 1 ) CPU , must lactate must nonchildbearing potential . Body mass index ( BMI ) 18 30 kg/m2 inclusive weigh least 50 kg 100 kg inclusive . FEV1 &gt; 80 % predict normal value . History severe allergy/hypersensitivity ongoing clinically important allergy/hypersensitivity , judge Investigator history hypersensitivity drug similar chemical structure class AZD7624 History clinically important disease disorder , opinion Investigator , may either put subject risk participation study , influence result subject 's ability participate study History family history muscle disease Known suspect history drug abuse judge Investigator Use prescribe nonprescribed medication include antacid , analgesic paracetamol/acetaminophen , herbal remedy , vitamin ( exclude routine vitamin include megadose [ intake 20 600 time recommended daily dose ] )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>Healthy Volunteers</keyword>
	<keyword>Single Ascending Dose ( SAD )</keyword>
	<keyword>First Time Man</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
</DOC>